A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

789

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Overactive Bladder
Interventions
DRUG

Oxybutynin topical gel

1 application daily to skin for 12 weeks

OTHER

Placebo topical gel

1 application daily to skin for 12 weeks

Trial Locations (63)

Unknown

Birmingham

Homewood

Mobile

Montgomery

Phoenix

Tucson

Little Rock

Anaheim

Buena Park

Laguna Woods

Sacramento

San Diego

Torrance

Denver

Waterbury

Aventura

Clearwater

DeLand

Leesburg

Ocala

Plantation

Tallahassee

West Palm Beach

Alpharetta

Atlanta

Belville

Chicago

Melrose Park

Evansville

South Bend

Shreveport

Watertown

Saginaw

Saint Joseph

Omaha

Las Vegas

Albuquerque

Albany

Garden City

New York

Williamsville

Winston-Salem

Cleveland

Columbus

Lyndhurst

Bethany

Edmond

Portland

Allentown

Newton

Philadelphia

West Reading

Warwick

Greer

Nashville

Austin

Corpus Christi

Dallas

Houston

San Antonio

Salt Lake City

Richmond

Spokane

Sponsors
All Listed Sponsors
lead

Watson Pharmaceuticals

INDUSTRY

NCT00350636 - A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo | Biotech Hunter | Biotech Hunter